Reversible splenial lesion syndrome associated with lobar pneumonia: Case report and review of literature
- PMID: 27684805
- PMCID: PMC5265898
- DOI: 10.1097/MD.0000000000004798
Reversible splenial lesion syndrome associated with lobar pneumonia: Case report and review of literature
Abstract
Background: Reversible splenial lesion syndrome (RESLES) is a rare clinico-radiological disorder with unclear pathophysiology. Clinically, RESLES is defined as reversible isolated splenial lesions in the corpus callosum, which can be readily identified by magnetic resonance imaging (MRI) and usually resolve completely over a period of time. RESLES could be typically triggered by infection, antiepileptic drugs (AEDs), poisoning, etc. More factors are increasingly recognized.
Methods and results: We reported herein an 18-year-old female patient with lobar pneumonia who developed mental abnormalities during hospitalization. An isolated splenial lesion in the corpus callosum was found by head MRI and the lesion disappeared 15 days later. Based on her clinical manifestations and radiological findings, she was diagnosed with lobar pneumonia associated RESLES. We further summarize the up-to-date knowledge about the etiology, possible pathogenesis, clinical manifestations, radiological features, treatment, and prognosis of RESLES.
Conclusion: This report contributes to the clinical understanding of RESLES which may present with mental abnormalities after infection. The characteristic imaging of reversible isolated splenial lesions in the corpus callosum was confirmed in this report. The clinical manifestations and lesions on MRI could disappear naturally after 1 month without special treatment.
Conflict of interest statement
The authors have no funding and conflicts of interest to disclose.
Figures




Similar articles
-
Sequential occurrence of eclampsia-associated posterior reversible encephalopathy syndrome and reversible splenial lesion syndrome (a case report): proposal of a novel pathogenesis for reversible splenial lesion syndrome.BMC Med Imaging. 2019 Apr 30;19(1):35. doi: 10.1186/s12880-019-0323-7. BMC Med Imaging. 2019. PMID: 31039748 Free PMC article.
-
Clinical analysis of reversible splenial lesion syndrome in Chinese adults: A retrospective study of 11 cases.Medicine (Baltimore). 2020 Sep 4;99(36):e22052. doi: 10.1097/MD.0000000000022052. Medicine (Baltimore). 2020. PMID: 32899066 Free PMC article.
-
Reversible splenial lesion syndrome associated with encephalitis/encephalopathy presenting with great clinical heterogeneity.BMC Neurol. 2016 Apr 18;16:49. doi: 10.1186/s12883-016-0572-9. BMC Neurol. 2016. PMID: 27089920 Free PMC article.
-
Reversible splenial lesion syndrome in children: Retrospective study and summary of case series.Brain Dev. 2016 Nov;38(10):915-927. doi: 10.1016/j.braindev.2016.04.011. Epub 2016 Aug 30. Brain Dev. 2016. PMID: 27591118 Review.
-
Non-severe COVID-19 complicated by cytotoxic lesions of the corpus callosum (mild encephalitis/encephalopathy with a reversible splenial lesion): a case report and literature review.Int J Infect Dis. 2022 Dec;125:1-9. doi: 10.1016/j.ijid.2022.09.009. Epub 2022 Sep 16. Int J Infect Dis. 2022. PMID: 36122669 Free PMC article. Review.
Cited by
-
Mild encephalitis/encephalopathy with a reversible splenial lesion secondary to encephalitis complicated by hyponatremia: A case report and literature review.Medicine (Baltimore). 2019 Nov;98(47):e17982. doi: 10.1097/MD.0000000000017982. Medicine (Baltimore). 2019. PMID: 31764808 Free PMC article. Review.
-
Reversible splenial lesion syndrome in children: a retrospective study of 130 cases.Front Neurol. 2023 Sep 5;14:1241549. doi: 10.3389/fneur.2023.1241549. eCollection 2023. Front Neurol. 2023. PMID: 37731857 Free PMC article.
-
Reversible splenial lesion syndrome in sisters with sensorineural deafness as the first manifestation.Heliyon. 2021 May 26;7(5):e07057. doi: 10.1016/j.heliyon.2021.e07057. eCollection 2021 May. Heliyon. 2021. PMID: 34113728 Free PMC article.
-
Reversible splenial lesion syndrome due to oxcarbazepine withdrawal: case report and literature review.J Int Med Res. 2018 Mar;46(3):1277-1281. doi: 10.1177/0300060517736452. Epub 2018 Jan 11. J Int Med Res. 2018. PMID: 29322880 Free PMC article.
-
Reversible splenial lesion syndrome (RESLES) due to acute intermittent porphyria with a novel mutation in the hydroxymethylbilane synthase gene.Orphanet J Rare Dis. 2020 Apr 19;15(1):98. doi: 10.1186/s13023-020-01375-y. Orphanet J Rare Dis. 2020. PMID: 32306994 Free PMC article.
References
-
- Kim SS, Chang KH, Kim ST, et al. Focal lesion in the splenium of the corpus callosum in epileptic patients: antiepileptic drug toxicity? AJNR Am J Neuroradiol 1999; 20:125–129. - PubMed
-
- Tada H, Takanashi J, Barkovich AJ, et al. Clinically mild encephalitis/encephalopathy with a reversible splenial lesion. Neurology 2004; 63:1854–1858. - PubMed
-
- Garcia-Monco JC, Cortina IE, Ferreira E, et al. Reversible splenial lesion syndrome (RESLES): what's in a name? J Neuroimaging 2011; 21:e1–14. - PubMed
-
- Oliphant CM, Green GM. Quinolones: a comprehensive review. Am Fam Physician 2002; 65:455–464. - PubMed
-
- Oztoprak I, Engin A, Gumus C, et al. Transient splenial lesions of the corpus callosum in different stages of evolution. Clin Radiol 2007; 62:907–913. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical